
ITI Pharma and Healthcare Fund Direct - Growth
ITI Pharma and Healthcare Fund Direct - Growth
as on 08 Jul 2026
ITI Pharma and Healthcare Fund Direct - Growth is a Equity mutual fund scheme launched on 11 Nov 2021. Investors can begin their investment journey with a minimum SIP of ₹500 or a lumpsum investment of ₹5,000. The fund manages total assets worth ₹237.99 crores, and the current NAV stands at ₹18.9548 as of 08 Jul 2026. The fund has delivered absolute returns of 7.04% in the past 1 year. For the last 3 years the fund has delivered a CAGR of 21.56%. The expense ratio of the fund is 0.68%.
NAV ₹ 18.9548 (-1.22%)
NAV
NIFTY50
NAV
NIFTY50
NAV ₹ 18.9548 (-1.22%)
CompareReturns Calculator
basis annualised returns
Investment Type
SIP Amount
Investment Period
3Y
₹ 18.95 L
3.50%
₹ 20.40 L
8.00%
₹ 25.45 L
21.56%
Total Investment
₹ 18,00,000
Returns
₹ 7,45,357 (21.56%)
Maturity Value
₹ 25,45,357
Disclaimer: Fixed deposits offer guaranteed returns. Mutual fund investments carry market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns.
Direct vs Regular Returns
Sorry, No Data Available at this Moment!
Returns vs Category
Sorry, No Data Available at this Moment!
*The above returns are absolute
Returns Vs Nifty 50
Historical Returns
Sorry, No Data Available at this Moment!
Start SIP with as Low as ₹100.
Historical NAV
Sorry, No Data Available at this Moment!
Asset Allocation
AUM
₹ 237.99 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Asset Allocation
AUM
₹237.99 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Sector Holdings
Sorry, No Data Available at this Moment!
Stock Holdings
Sorry, No Data Available at this Moment!
Fund Comparison
Fund Details
52W High NAV
₹ 19.3474
Min. SIP Amount
₹ 500.00
Min. Lumpsum Amount
₹ 5,000.00
AUM (in Cr.)
₹ 237.99
Expense Ratio
0.68%
Lock-in Period
No Lock in Period
52W Low NAV
₹ 15.7876
Inception Date
11 Nov 2021
Fund Age
4 Yrs
Benchmark
NIFTY Healthcare TRI
Scheme Type
Open Ended
Stamp Duty
0.005% (from July 1st 2020)
Exit Load
- Exit load of 0.50%, if redeemed within 3 months.
Tax Implication
- If you redeem within 1 year, STCG are taxed at 20%; If you redeem after 1 year, and returns exceed ₹1.25 Lakhs in a financial year, LTCG are taxed at 12.5%
Fund Managers
| Name | Qualification |
|---|---|
| Nilay Dalal | MBA (Finance) |
| Rajesh Bhatia | CFA, AIMR, Associate of Cost and Management Accounting, B.Com |
| Animesh Singh | NA |
Fund Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Risk-O-Meter
Investors understand that their principal will be at
Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
ITI Mutual Fund
No. of Schemes
20
Total AUM
₹ 11,383.14 Cr
Contact Details
ITI House 36, Dr.R.K.Shirodkar Marg,Parel Mumbai - 400012.
Contact Details
ITI House 36, Dr.R.K.Shirodkar Marg,Parel Mumbai - 400012.
Open NFOs
Sorry, No Data Available at this Moment!
FAQs
When was ITI Pharma and Healthcare Fund launched?
What is the current NAV of ITI Pharma and Healthcare Fund?
What is the AUM of ITI Pharma and Healthcare Fund?
What is the rate of return of ITI Pharma and Healthcare Fund?
- In the past 1Y: 7.04%
- In the past 3Y: 21.56%
- In the past 5Y: 0.00%
What is the expense ratio of ITI Pharma and Healthcare Fund?
What is exit load of ITI Pharma and Healthcare Fund?
What is the portfolio of ITI Pharma and Healthcare Fund?
No data to show right now!
Top 3 sectoral holdings include:
How risky is investing in ITI Pharma and Healthcare Fund?
Who is the fund manager ITI Pharma and Healthcare Fund?
What is the minimum investment required in ITI Pharma and Healthcare Fund?
How to invest in ITI Pharma and Healthcare Fund directly?
- Open Demat Account on Dhan if you don't have one.
- Analyze the fund performance.
- Invest via SIP or Lumpsum.



